Navigation Links
NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
Date:4/15/2008

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract infection, UTI.

In experiments performed at the Karolinska University Hospital in Sweden, researchers showed that technology developed by NOLabs AB proved to have a high effectiveness in killing pathogens, typically for those causing UTI including an aggressive strain of E. coli. Millions of patients annually acquire UTI while being hospitalized for treatment of other diseases. Preventing such infection has the potential to dramatically reduce the amount of antibiotics used as well as improving quality of life for a large number of hospitalized patients.

Goran Beijer, CEO of NOLabs says; "We are happy to have taken another important step in developing products that have a huge potential to prevent millions of UTI cases globally every year. The anti-microbial effect of NO will be essential in a range of innovative products that prevent and/or treat infection. We expect to have the first products on the market in early 2009."

Professor Peter Wiklund, Karolinska University says; "This new technology has a huge potential to reduce the usage of Antibiotics and thereby the risk of antibiotic resistance as well as reducing the risk of urosepsis, the severest and potentially lethal consequence of UTI."

NOLabs is developing products that will prevent catheter related urinary tract infections, products that will be effective on reducing neuropathic pain and wound care products with an anti-bacterial effect.

NOLabs is a Swedish bio-medtech company focusing on the development and marketing of Nitric Oxide-containing medical devices for various medical applications. Nitric Oxide is a natural substance, produced by the human body controlling vaso-regulation and as part of its protection against pathogens. In particular, NOLabs focuses on developing effective Nitric Oxide based products and therapies that prevent infection and provide pain relief for millions of patients suffering from diabetes-related complications such as chronic wounds and neuropathic pain. Another focus area is the prevention and treatment of urinary tract infections. NOLabs has developed innovative, cost efficient and highly effective technologies that have a significant potential to address serious health issues that impact the lives of over 100 million people.

Goran Beijer

e-mail: goran.beijer@nolabs.com

Phone: +46-706-636-009

Susanne Goransson

e-mail:susanne.goransson@nolabs.com

Phone: +46-42-33-65-21


'/>"/>
SOURCE NOLabs AB
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
(Date:3/29/2017)... 29, 2017 NetworkNewsWire Editorial Coverage  ... There are ... in regulating marijuana, but economic arguments also favor its legalization. ... law enforcement costs. However, to legalize and regulate marijuana requires ... Inc. (OTC: SING) ( SING Profile ), American Cannabis Company ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... published in a research report by Grand View Research, Inc., projects that ... billion by 2025. The projection takes into consideration the continuous successful legalization ... open approach towards cannabis products around the world. In 2016, states - ... North Dakota , Ohio , and ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... In the United States alone, up to 36% of primary brain tumors ... brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known to grow ... options, the San Diego Gamma Knife Center offers a precision-medicine based solution ...
(Date:3/29/2017)... , ... March 30, 2017 , ... CHARM CITY RUN ... Run has announced that Mercy Medical Center will serve as the official title sponsor ... region. On Sunday, June 25, 2017, thousands of women will walk or run the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... hosting several educational opportunities for attending prescribers at the upcoming World Congress, in ... said, “A4M has always been recognized as the visionary leader in the training ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... in Carnegie, OK, from Dr. Jamie Cameron, with or without a referral. ... to traditional orthodontic treatment. Depending on each patient’s case, treatment with the FASTBRACES ...
(Date:3/29/2017)... Chicago, Illinois (PRWEB) , ... March 29, 2017 ... ... Visio Stencils Device Library for documenting and diagramming network and data center assets ... , NetZoom subscribers can request new equipment shapes for free and download ...
Breaking Medicine News(10 mins):